The Fanconi Anemia Pathway Promotes Replication-Dependent DNA Interstrand Cross-Link Repair

Puck Knipscheer(Harvard University), Markus Räschle(Max Planck Institute of Biochemistry), Agata Smogorzewska(Brigham and Women's Hospital), Milica Enoiu(University of Zurich), The Vinh Ho(Stony Brook University), Orlando D. Schärer(University of Zurich), Stephen J. Elledge(Brigham and Women's Hospital), Johannes C. Walter(Harvard University)
Science
November 12, 2009
Cited by 529

Abstract

Fanconi anemia is a human cancer predisposition syndrome caused by mutations in 13 Fanc genes. The disorder is characterized by genomic instability and cellular hypersensitivity to chemicals that generate DNA interstrand cross-links (ICLs). A central event in the activation of the Fanconi anemia pathway is the mono-ubiquitylation of the FANCI-FANCD2 complex, but how this complex confers ICL resistance remains enigmatic. Using a cell-free system, we showed that FANCI-FANCD2 is required for replication-coupled ICL repair in S phase. Removal of FANCD2 from extracts inhibits both nucleolytic incisions near the ICL and translesion DNA synthesis past the lesion. Reversal of these defects requires ubiquitylated FANCI-FANCD2. Our results show that multiple steps of the essential S-phase ICL repair mechanism fail when the Fanconi anemia pathway is compromised.


Related Papers

No related papers found

Powered by citation graph analysis